IntelGenx Technologies Corp.
IGX
Kedudukan dalam Saham
#28106
IntelGenx Technologies Corp. is a pharmaceutical drug delivery enterprise... IntelGenx Technologies Corp. is a pharmaceutical drug delivery enterprise focused on the creation and manufacturing of advanced oral thin film products. The company's diverse product pipeline encompasses various oral film formulations designed to address a wide spectrum of medical conditions. These include INT0008/2008, a Rizatriptan film for migraine management; INT0046/2018 for adult applications; INT0007/2006, an oral film targeting erectile dysfunction; INT0043/2015, a montelukast-based film for Alzheimer's disease; INT0027/2011, intended for opioid addiction treatment; INT0010/2006, addressing neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, formulated for schizophrenia or bipolar I disorder; and INT0048/2020, developed for veterinary health. Additionally, IntelGenx is actively developing other candidates identified as INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has established strategic partnerships, including a comprehensive licensing, development, and supply agreement with Tilray, Inc., alongside a development pact with Cynapsus Therapeutics Inc. Founded in 2003, IntelGenx Technologies Corp. is headquartered in Montreal, Canada.
Harga Saham
$0.17446996
Disegerakkan terakhir: 2024-06-11
Modal Pasaran
$26.97M
Perubahan (1 hari)
-0.57%
Perubahan (1 tahun)
2.63%
Negara
CA
Perdagangan IntelGenx Technologies Corp. (IGX)
Kategori
Healthcare
Pendapatan untuk IntelGenx Technologies Corp. (IGX)
Pendapatan pada Mar 2024 TTM: $-11.03M
Menurut laporan kewangan terkini IntelGenx Technologies Corp., pendapatan semasa syarikat ialah $-11.03M. Pada tahun 2022, syarikat memperoleh pendapatan sebanyak $-10.69M, penurunan berbanding pendapatan pada tahun 2021 yang berjumlah $-9.32M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi IntelGenx Technologies Corp. dari 2003 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Ubah |
|---|---|---|
| 2026 (TTM) | $-11.03M | 11.11% |
| 2023 | $-9.93M | -7.14% |
| 2022 | $-10.69M | 14.72% |
| 2021 | $-9.32M | 32.28% |
| 2020 | $-7.04M | -33.92% |
| 2019 | $-10.66M | 5.46% |
| 2018 | $-10.11M | 231.30% |
| 2017 | $-3.05M | 158.56% |
| 2016 | $-1.18M | -191.40% |
| 2015 | $1.29M | -173.94% |
| 2014 | $-1.75M | 6.53% |
| 2013 | $-1.64M | -27.16% |
| 2012 | $-2.25M | -8.24% |
| 2011 | $-2.45M | -20.80% |
| 2010 | $-3.10M | 49.51% |
| 2009 | $-2.07M | -30.00% |
| 2008 | $-2.96M | 153.92% |
| 2007 | $-1.16M | 49.13% |
| 2006 | $-781.14K | 0.00% |
| 2005 | 0.00 | 0.00% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | 0.00% |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| $5.27B | -47,923.21% |
US
|
|
| $-3.09B | 27,887.31% |
US
|
|
| $-4.02B | 36,311.57% |
AU
|
|
| - | - |
CH
|
|
| $1.95B | -17,784.95% |
NL
|
